These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
693 related items for PubMed ID: 9614594
1. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients. Sandor P, Baker B, Irvine J, Dorian P, McKessok D, Mendlowitz S. Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594 [Abstract] [Full Text] [Related]
2. Course of psychomotor agitation during pharmacotherapy of depression: analysis from double-blind controlled trials with fluoxetine. Tollefson GD, Sayler ME. Depress Anxiety; 1998; 4(6):294-311. PubMed ID: 9166658 [Abstract] [Full Text] [Related]
3. Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline. Marchesi C, Ceccherininelli A, Rossi A, Maggini C. Pharmacopsychiatry; 1998 Nov; 31(6):216-21. PubMed ID: 9930635 [Abstract] [Full Text] [Related]
4. Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder. Baker B, Dorian P, Sandor P, Shapiro C, Schell C, Mitchell J, Irvine MJ. J Clin Psychopharmacol; 1997 Feb; 17(1):15-21. PubMed ID: 9004052 [Abstract] [Full Text] [Related]
5. Predictors of an acute antidepressant response to fluoxetine and sertraline. Flament MF, Lane RM, Zhu R, Ying Z. Int Clin Psychopharmacol; 1999 Sep; 14(5):259-75. PubMed ID: 10529069 [Abstract] [Full Text] [Related]
6. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline. Joyce PR, Mulder RT, McKenzie JM, Luty SE, Cloninger CR. Depress Anxiety; 2004 Sep; 19(3):180-6. PubMed ID: 15129420 [Abstract] [Full Text] [Related]
7. A multicentre open trial of fluoxetine in depressed out-patients in Belgium. Brasseur R. Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():107-11. PubMed ID: 2644335 [Abstract] [Full Text] [Related]
8. Fluoxetine versus trimipramine in the treatment of depression in geriatric patients. Wehmeier PM, Kluge M, Maras A, Riemann D, Berger M, Kohnen R, Dittmann RW, Gattaz WF. Pharmacopsychiatry; 2005 Jan; 38(1):13-6. PubMed ID: 15706460 [Abstract] [Full Text] [Related]
9. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up. Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U. J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027 [Abstract] [Full Text] [Related]
15. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, Jamshidi AH. J Ethnopharmacol; 2005 Feb 28; 97(2):281-4. PubMed ID: 15707766 [Abstract] [Full Text] [Related]
16. A double-blind parallel study to compare fluoxetine with doxepin in the treatment of major depressive disorders. Tamminen TT, Lehtinen VV. Int Clin Psychopharmacol; 1989 Jan 28; 4 Suppl 1():51-6. PubMed ID: 2783699 [No Abstract] [Full Text] [Related]
17. Are neurovegetative symptoms stable in relapsing or recurrent atypical depressive episodes? Nierenberg AA, Pava JA, Clancy K, Rosenbaum JF, Fava M. Biol Psychiatry; 1996 Oct 15; 40(8):691-6. PubMed ID: 8894060 [Abstract] [Full Text] [Related]
18. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients. Diaz A, Fouilloux C, Ortiz S. Proc West Pharmacol Soc; 2002 Oct 15; 45():154-5. PubMed ID: 12434564 [No Abstract] [Full Text] [Related]